BDNF and Alzheimer disease: In addition to AD patients, transgenic AD mouse models also show reduced mBDNF expression and decreased mBDNF/proBDNF levels in the hippocampus [247–249], indicating the involvement of altered cleavage of BDNF in AD pathology.